
Japanese pharmaceutical company Daiichi Sankyo Co. announced Monday it had agreed to acquire US company Ambit Biosciences for $410 million.
The company said the move was a bid to establish its presence in the oncology field. Oncology is a branch in medicine that deals with tumors.
The Japanese company will need to spend $315 million to acquire all the stocks of Ambit Biosciences, a joint statement said. Sankyo President Joji Nakayama said in the statement that the move will ensure Sankyo will continue to provide innovative pharmaceuticals in areas that are unmet in terms of medical need.
GMT 17:56 2018 Wednesday ,17 January
Ericsson to write down 1.4 billion euros in fourth quarterGMT 19:16 2018 Saturday ,13 January
China shuts Marriott website over Tibet error, scolds other firmsGMT 17:31 2018 Thursday ,11 January
UK group bids for Europe's biggest aluminium smelterGMT 17:24 2018 Thursday ,11 January
UK supermarket Sainsbury's lifts outlook after bumper ChristmasGMT 17:52 2018 Tuesday ,09 January
H&M removes 'black boy' ad after racism accusationGMT 19:38 2018 Wednesday ,03 January
Petrobras pay $2.95bn to settle US class action on corruptionGMT 13:49 2018 Wednesday ,03 January
China’s Ant Financial drops $1.2 billion MoneyGram deal as US approval failsGMT 17:47 2017 Sunday ,31 December
BA owner to buy bankrupt Austrian airline Niki
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor